The Westminster lensArchive · Written questions · 171 tabled · 169 answered

Written questions by Roberts.

Every parliamentary written question tabled by Liz Saville Roberts this session, with the full answer and department. Back to the MP page.

Department:All (171)Ministry of Justice (62)Department for Energy Security and Net Zero (39)Home Office (22)Ministry of Defence (9)Wales Office (7)Department for Work and Pensions (6)Department of Health and Social Care (5)Department for Transport (5)Department for Culture, Media and Sport (3)Cabinet Office (3)Department for Environment, Food and Rural Affairs (3)Treasury (2)

Showing 15 of 5 · Department of Health and Social Care

9 Jul 2025·Department of Health and Social Care·Answered
Asked

What assessment he has made of trends in the level of demand for medical radionuclides in the NHS in the next (a) 5, (b) 10, (c) 15 and (d) 20 years.

Reply

The Department has not made a specific assessment. The Department regularly engages with suppliers, specialist clinicians, the British Nuclear Medicine Society, and the UK Radiopharmacy Group to support the continued supply of medical radioisotopes for National Health Services. There are six trusted research reactors which play a critical role in global radiopharmaceutical production, none of which are in the United Kingdom. The Department continues to work with the NHS and other parts of the Government, and the devolved administrations, to better understand future needs for medical radioisotopes.From an NHS perspective, as part of making available new treatments and interventions, consideration is given to a range of factors, including demand and supply. The NHS has got processes in place to escalate and manage business continuity, including medicines supply.

9 Jul 2025·Department of Health and Social Care·Answered
Asked

What discussions his Department has had with the devolved Administrations on the (a) need and (b) potential ability for the UK to create radionuclides for use in healthcare.

Reply

The Department has not made a specific assessment. The Department regularly engages with suppliers, specialist clinicians, the British Nuclear Medicine Society, and the UK Radiopharmacy Group to support the continued supply of medical radioisotopes for National Health Services. There are six trusted research reactors which play a critical role in global radiopharmaceutical production, none of which are in the United Kingdom. The Department continues to work with the NHS and other parts of the Government, and the devolved administrations, to better understand future needs for medical radioisotopes.From an NHS perspective, as part of making available new treatments and interventions, consideration is given to a range of factors, including demand and supply. The NHS has got processes in place to escalate and manage business continuity, including medicines supply.

9 Jul 2025·Department of Health and Social Care·Answered
Asked

What assessment he has made of the adequacy of the (a) availability and (b) supply of medical radionuclides for NHS use in the next (i) 5, (ii) 10, (iii) 15 and (iv) 20 years.

Reply

The Department has not made a specific assessment. The Department regularly engages with suppliers, specialist clinicians, the British Nuclear Medicine Society, and the UK Radiopharmacy Group to support the continued supply of medical radioisotopes for National Health Services. There are six trusted research reactors which play a critical role in global radiopharmaceutical production, none of which are in the United Kingdom. The Department continues to work with the NHS and other parts of the Government, and the devolved administrations, to better understand future needs for medical radioisotopes.From an NHS perspective, as part of making available new treatments and interventions, consideration is given to a range of factors, including demand and supply. The NHS has got processes in place to escalate and manage business continuity, including medicines supply.

9 Jul 2025·Department of Health and Social Care·Answered
Asked

What contingency plans the NHS has put in place to manage a potential shortage in the supply of medical radionuclides to prevent delays to (a) cancer, (b) cardiac and (c) other procedures.

Reply

The Department has not made a specific assessment. The Department regularly engages with suppliers, specialist clinicians, the British Nuclear Medicine Society, and the UK Radiopharmacy Group to support the continued supply of medical radioisotopes for National Health Services. There are six trusted research reactors which play a critical role in global radiopharmaceutical production, none of which are in the United Kingdom. The Department continues to work with the NHS and other parts of the Government, and the devolved administrations, to better understand future needs for medical radioisotopes.From an NHS perspective, as part of making available new treatments and interventions, consideration is given to a range of factors, including demand and supply. The NHS has got processes in place to escalate and manage business continuity, including medicines supply.

6 May 2025·Department of Health and Social Care·Answered
Asked

If he will make an assessment of the potential merits of establishing an independent inquiry into the death of Robbie Powell in 1990.

Reply

The Government offers its deepest sympathy to the parents of Robbie Powell for the tragic loss of their son in 1990.Robbie Powell’s death has been the subject of a number of investigative and judicial processes over the last 30 years. The intense scrutiny of Robbie’s case, provided through these reviews, suggests that it is unlikely that a further inquiry would reveal anything which has not been uncovered already, or would identify further significant lessons to be learned.Even though the events occurred prior to the devolution of the National Health Service, this should not prevent the National Assembly for Wales from considering this case.

Sources
SourceUK Parliament Members API
MethodQuestion and answer text as published. Question preamble (“To ask the…”) trimmed for readability; answers shown in full.